How can ophthalmologists better educate patients about the severity of DME progression?
EyePoint Pharmaceuticals reports positive 16-week interim results from Phase 2 VERONA trial of Duravyu for diabetic macular edema
Sterile intraocular inflammation associated with faricimab
Oculis to present phase 3 DIAMOND program updates at Innovate Retina and Eyecelerator 2024
UNITY Biotechnology to host in-person and virtual Ophthalmology Day
Everads Therapy presented on first-in-human study of the Everads Injector for suprachoroidal administration at EURETINA 2024
Early-stage macular vascular and photoreceptor changes in DME